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ABSTRACT 
Many approaches have been immerged to prolong the residence time of the dosage forms at the absorption site .One among them is the 
development of oral controlled release mucoadhesive system. The present study aims to formulate and evaluate the effectiveness of FSM-
Alginate beads of Vildagliptin in streptozotocin induced diabetic rats. In the present work, 6 formulations of Vildagliptin mucoadhesive beads 
(F1 to F6) were prepared by ionotropic gelation method. Fenugreek seed mucilage and sodium alginate was used as polymers and calcium 
chloride as cross linking agent. The beads containing drugs and excipients were subjected to various evaluation test such as Particle size 
distribution, Swelling index, Mucoadhesivity and Dissolution studies. Among all the formulations, F3 containing FSM and sodium alginate in the 
concentration of 0.6g and % DEE of 97.89 resulting in the highest drug release rate of 97.86% at the end of 10 h. Hence, it w as considered as the 
optimized formulation. 
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1. INTRODUCTION: 
Over the previous few decades, a great deal of interest has 
been paid to the development of polysaccharide-based 
hydrogel beads thru ionotropic gelation technique, which 
are useful as achievable carriers in controlled drug delivery. 
The benefit of physical cross-linking by way of ionotropic 
gelation is that the drug encapsulation in the beads could be 
carried out in an eco-friendly environment avoiding the 
feasible toxicity of reagents associated with chemical cross-
linking. To formulate numerous cross-linked alginate 
mucoadhesive systems for controlled-release drug delivery, 
use of mucoadhesive polymer-blend with alginate is one of 
the generally accepted approaches. Again, blending with 
suitable polymer can enhance drug encapsulation and 
stability, which are found lower in cross-linked alginate 
hydrogel beads processed by ionotropic gelation. 
FSM was obtained   from Trigonella foenum-graecum L. seeds 
known as Methi and is a commonly reachable material in 
nature. Fenugreek seeds comprise a high percentage of 
mucilage. The pharmaceutical utility of FSM is already 
established as mucoadhesive gelling agent, binding agent, 
and disintegrating agent. It is additionally suggested that the 
FSM has antidiabetic property .In the present study, the 
utility of FSM, as a possible herbal mucoadhesive polymeric-
blend with sodium alginate for the development of a novel 
mucoadhesive beads through ionotropic gelation technique 
for the use in oral delivery was evaluated using Vildagliptin 
as model drug. [1, 2, 3] 
Vildagliptin is a new oral antidiabetic drug that enhances 
pancreatic islet cell responsiveness to glucose. Vildagliptin 
trade names Galvus, Zomelis,) is an oral anti-hyperglycemic 
agent (anti-diabetic drug) of the dipeptidyl peptidase-4 
(DPP- 4) inhibitor classification of drugs. Vildagliptin 
inhibits the inactivation of GLP-1and GIP via DPP-4, 
permitting GLP-1 and GIP to potentiate the secretion of 
insulin in the beta cells and suppress glucagon release by 
using the alpha cells of the islets of Langerhans in the 
pancreas. Vildagliptin has been shown to limit 
hyperglycemia in type 2 diabetes mellitus. Biological half-life 
2-4 hrs. Main site of absorption is at small intestine. 
Therefore, the study used to be planned with an aim of 
developing a herbal polysaccharide-based more than one 
unit mucoadhesive system of Vildagliptin by the use of 
sodium alginate-FSM polymer-blend for controlled-release 
oral drug delivery [4,5]. 
2. MATERIALS AND METHODS 
2.1 Materials  
Vildagliptin (Yarrow Chem Products, Mumbai), Sodium 
Alginate (Loba Chemi India), Calcium Chloride (Nice 
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Chemicals) and Fenugreek seeds were collected from 
Chertahla in the month of February 2019. All the reagents 
and chemicals are of analytical grade. 
2.2 Extraction and purification of Fenugreek Seed 
Mucilage: 
Seeds are washed to get rid of dirt and particles. The 
fenugreek seeds (250 g) had been soaked in distilled water 
(500ml) overnight time and heated at 50ºC for 2 hours. The 
mucilage is extracted using multilayer material bag to take 
away the mare from the solution. Acetone was added to the 
above filtrate to precipitate the mucilage and therefor the 
mucilage was separated, dried in an oven at 50ºC, keep in 
desiccator until use. The acquired powder was re-dissolved 
in a hundred ml of water, filtered and centrifuged for 20 
minutes at 3000rpm.The supernatant clear answer was 
evaporated and dried. The purified stable mass was dried 
and saved in an air tight container.[1,17] 
2.3 Preparation of FSM –alginate beads containing 
Vildagliptin 
The mucoadhesive beads could be prepared via Ionotropic 
Gelation Method (IG).  Sodium alginate and FSM aqueous 
dispersions were organized separately by using of distilled 
water.  With a magnetic stirrer, these dispersions were well 
blended with stirring at 200-400 rpm for 10 min. 
Vildagliptin was then added to the dispersion aggregate. 
Using magnetic stirrer, drug and polymers will be dissolved 
entirely in water. The stirring is sustained until clear 
dispersion is formed, then this dispersion is dropped 
through a satisfactory needle 21-G in to calcium chloride 
(CaCl2) solution. In the CaCl2 solution, the added droplets 
were retained for 15 min to complete the healing reaction 
and to produce rigid beads. The beads was filtered, washed 
with distilled water and dried at room temperature. 
 
Table 1 Formulation Chart. 
INGREDIENTS(mg) F1 F2 F3 F4 F5 F6 
VILDAGLIPTIN 500 500 500 500 500 500 
SODIUM ALGINATE 100 200 300 400 500 600 
FSM MUCILAGE 100 200 300 400 500 600 
CALCIUM CHLORIDE 2 2 2 2 2 2 
 
2.4 CHARECTERIZATION METHODS 
2.4.1 Fourier Transform Infra-Red Spectroscopy: 
The compatibility between pure drug and polymer was 
detected by FT-IR spectra obtained. Samples were reduced 
to powder and analyzed as KBr pellets by employing a 
Fourier transform-infrared (FTIR) spectroscope (Perkin 
Elmer Spectrum RX I, USA). The pellet was placed within the 
sample holder. Spectral scanning was taken within the 
wavelength region between 4000 and 400 cm−1 at a 
resolution of 4 cm−1 with scan speed of 1 cm/s. 
2.4.2 Surface Morphology Analysis by Scanning Electron 
Microscopy (SEM):  
 Beads having drug were gold coated by mounted on a brass 
stub using double-sided adhesive tape and under vacuum in 
an ion sputter with a tiny layer of gold (3–5 nm) for 75 s and 
at 20 kV to make them electrically conductive and their 
morphology was observed by scanning electron microscope 
(ZEISS EVO 40, Japan). 
2.4.3 Bead Size Measurement  
Particle size of 100 dried beads from every batch was 
measured by optical microscopic technique for average 
particle size using an optical microscope (Olympus). The 
ocular micrometer was formerly calibrated by stage 
micrometer. 
2.4.4 Determination of DEE 
100 mg of beads were taken and were crushed using pestle 
and mortar. The crushed powders of drug containing beads 
were placed in a very 250 ml volumetric flask and the 
volume was made up to 250 ml by phosphate buffer, pH 7.4, 
and kept for 24 h with infrequently shaking at 37 ± 0.5 ◦ C. 
After the specified time, the mixture was stirred at 500 rpm 
for 20 min by means of a magnetic stirrer (Remi Motors, 
India). The polymer debris fashioned after disintegration of 
bead was removed by filtering through Whatman® filter 
paper (No. 40). The drug content within the filtrate was 
determined using a UV–vis spectrophotometer (Shimadzu, 
Japan) at 233 nm against acceptable blank. The DEE (%) of 
these prepared beads was calculated by the subsequent 
formula.          
         DEE (%) =     : 
                                 
                                     
     
2.4.5 Evaluation of Swelling Behavior  
Swelling behavior analysis of beads containing drug were 
carried out in two different aqueous media: 0.1 N HCl (pH 
1.2), and phosphate buffer (pH 7.4). 100 mg beads were 
placed in vessels of dissolution equipment (Campbell 
Electronics, India) containing 500 ml corresponding media. 
The experiment was carried out at 37 ± 1 ◦ C under 50 rpm 
paddle speed. The swelled beads were removed at scheduled 
time interval and weighed after drying the surface, by using 
a tissue paper. Swelling index was resolved by using the 
following formula: 
    Swelling index (%) =  
                                                       
                   
     
2.4.6 Ex- vivo Mucoadhesion Testing. 
The mucoadhesive properties of beads containing drug were 
evaluated by ex vivo wash-off methodology. Freshly excised 
pieces of goat intestinal mucosa (2 cm × 2 cm) (collected 
from slaughterhouse) were mounted on glass slide (7.5 cm × 
2.5 cm) using thread. About 50 beads were unfold onto the 
wet tissue specimen, and the prepared slide was slung onto 
a groove of disintegration test apparatus. The tissue 
specimen was given a even up and down movement in a 
vessel containing 900 ml of 0.1 N HCl (pH 1.2) and 
phosphate buffer (pH 7.4), separately, at 37 ± 0.5 ◦ C. After 
regular time intervals, the machine was stopped and 
therefore the range of beads still adhering to the tissue was 
counted. 
2.4.7 In Vitro Drug Release Studies. 
The release of drug from numerous beads was tested using 
dissolution equipment USP (Campbell Electronics, India). 
The baskets were enclosed with 100-mesh nylon cloth to 
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stop the seepage of the beads. The dissolution rates were 
measured at 37 ± 1 ◦ C under 50 rpm speed. Accurately 
weighed quantities of beads containing Vildagliptin 
equivalent to 100 mg were added to 900 ml of 0.1 N HCl (pH 
1.2). The test was carried out for 2 h and then continued in 
phosphate buffer (pH 7.4) for next 8 h. 5 ml of aliquots was 
collected at regular time intervals, and therefore the same 
quantity of fresh dissolution medium was replaced into 
dissolution vessel to keep the sink condition throughout the 
experiment. The collected aliquots were filtered, and 
suitably diluted to determine the absorbance using a UV–vis 
spectrophotometer (Shimadzu, Japan) at 233 nm against 
suitable blank.  
2.4.8 Drug Release Kinetic Data  
In order to understand the kinetics and mechanism of drug 
release, the result of in-vitro drug release study of beads 
were fitted with various kinetic equation like zero order 
(cumulative % release vs. time), Kosmeyer Peppas model 
,Higuchi’s model (cumulative % drug release vs. square root 
of time). R2 values were calculated for the linear curve 
obtained by regression analysis of the above plots. 
 
Table 2: Results of various studies like particle size determination, %DEE and in-vitro drug release 
 
SI NO 
 
FORMULATION CODE 
 
MEAN PARTICLE 
SIZE(mm) 
 
%DEE 
 
%DRUG RELEASE 
1 F1 1.37 96.45 96.42 
2 F2 1.35 95.29 94.20 
3 F3 1.28 97.89 97.86 
4 F4 1.36 96.65 96.49 
5 F5 1.37 95.49 94.74 
6 F6 1.39 95.86 95.76 
 
3. RESULTS AND DISCUSSION 
3.1 Fourier Transform Infra-Red Spectroscopy: 
The FTIR spectra of Sodium alginate, FSM, Vildagliptin and 
FSM alginate bead contain Vildagliptin were shown in the 
figure 1. The FTIR spectra of sodium alginate showed the 
band around 3440.92, 2931.73, 2160.23, 1620.18, 1419.59, 
and 1033.84cm-1 which are due to the stretching of  OH 
,CH,C=C,CF,CBr,=C-H respectively. FTIR spectrum of isolated 
FSM showed characteristic peaks of –OH between 3511.6 
and 3154.3 cm−1, –CH3 at 2925.48 cm−1,–CH stretching 
between 2920.0 and 2854.1cm−1, ether linkage at 1455–
1400 cm−1 and–CO stretching at 1017.7 cm−1.Absence of 
peaks indicates that there were no interaction among the 
polymers.
 
1.       3.  
2.         4.      
Fig:1 FTIR Spectrum 1: Vildagliptin,2:Sodim Alginate,3:FSM,4: Drug Polymer Mixture. 
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3.2 Surface Morphology Analysis by Scanning Electron 
Microscopy (SEM Analysis) 
 
Fig.2 Scanning electron photograph of optimized FSM-
Alginate bead containing Vildagliptin. 
The SEM photograph of the surface of the FSM-alginate bead 
of Vildagliptin (Fig. 2) exhibited very hard surface with 
characteristic massive wrinkles and cracks. These cracks and 
wrinkles may be caused via partly collapsing the polymeric 
gel network during drying. Due to the migration of beads 
along with water to the surface during drying will result in 
the formation of drug crystals. 
3.3 Bead Size Measurement. 
Particle of FSM-alginate beads of Vildagliptin was within the 
range of 1.28-1.39mm. Increasing the incorporation of FSM 
in the polymer solution with sodium alginate will increase 
the size of beads. Due to the increase in viscosity of the 
polymer blend solution with the addition of FSM in 
increasing ratio in turn increase the droplet size. A decrease 
in particle size of FSM alginate beads was seen when 
concentrated calcium chloride was used as cross linking 
agent. 
3.4 Determination of DEE 
 
Fig.3: Drug encapsulation efficiency of F1-F6 
formulations. 
 The drug encapsulation of beads was within the range of   
95.29 - 97.89. When the sodium alginate to FSM ratio in the 
polymer blend decreases, DEE % was increased. This may be 
due to the viscosity variations in the polymer blend. Thus 
the   leaching of the drug to the polymeric solution will be 
prevented during the time of cross linking. 
3.5 Evaluation of Swelling Behavior. 
Swelling behavior of optimized formulation F3 was carried 
out in 2 different medias.0.1N HCL pH1.2 and phosphate 
buffer pH7.4.When compared with phosphate buffer 
swelling behavior of FSM-alginate beads containing 
Vildagliptin was lower in acidic medium. This is because of 
the shrinkage of alginate at acidic medium. 
 
Fig.4 Swelling behavior of optimized formulation F3. 
Maximum swelling was observed in 3-4 hours in phosphate 
medium after that erosion and dissolution takes place. It has 
been previously reported that the swelling of calcium 
alginate in presence of calcium ion capturing agent depends 
on the progressive displacement of calcium ions within 
calcium alginate-based beads. It has been also reported that 
the swelling of calcium alginate-based beads can be 
enhanced by the presence of phosphate ions (in phosphate 
buffer), which act as calcium sequestrant. Thus this results 
clearly suggest that FSM –alginate beads containing 
Vildagliptin may slightly swell in the stomach and move to 
the upper intestine and the Vildagliptin is to be absorbed. 
3.6 Ex- vivo Mucoadhesion Testing. 
The ex vivo wash off test using goat intestinal mucosa for 
assessing Mucoadhesivity of FSM-alginate beads containing 
Vildagliptin was once performed at each gastric pH (0.1 N 
HCl, pH1.2) and intestinal pH (phosphate buffer, pH 7.4) for 
eight h. The wash off used to be faster at intestinal pH than 
at gastric pH. In acidic pH the percentage of beads adhere to 
the mucosal tissue varied from 70-87% in acidic buffer and 
90-50% in alkaline buffer. The decreased Mucoadhesion of 
FSM-alginate beads containing Vildagliptin in phosphate 
buffer may be resulted due to the erosion of calcium ion. 
Therefore, the results of the wash off test indicated that the 
FSM-alginate beads containing Vildagliptin possessed good 
mucoadhesivity. 
 
Fig.5 Mucoadhesivity of optimized formulation F3 
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3.7 In Vitro Drug Release Studies 
The In-vitro drug release for FSM –alginate beads containing 
Vildagliptin was carried out in 0.1 N HCL for 1st two hours 
and then in phosphate buffer for 8 hours. All the 6 
formulations showed prolonged release over 10 h. The drug 
release from the beads in acidic medium was slow due to the 
shrinkage of alginate in acidic pH (10.17%-20.04%). Due to 
the higher swelling rate in phosphate buffer drug release 
was found to be greater in phosphate buffer.(31.45%-
97.86%). 
 
 
Fig.6 The In-vitro drug release of Optimized Formulation F3 
 
3.8 Drug Release Kinetic Data: 
 
FORMULATIONS 
 
ZERO ORDER 
 
HIGUCHI 
 
KOSMEYER PEPPAS 
 
F3 
 
R2 
 
R2 
 
R2 
  
0.943 
 
0.877 
 
0.843 
The highest value of R2 indicates that the model follows zero order kinetics .For zero order R2 value was found to be: 0.943. 
 
4. CONCLUSION: 
Mucoadhesive beads containing Vildagliptin made of FSM-
alginate polymer-blend by ionotropic gelation technique was 
successfully prepared and evaluated. The above studies 
suggested that the FSM-alginate mucoadhesive beads 
containing Vildagliptin swelled slowly in the stomach and 
accordingly adhered to the stomach mucosa allowing more 
drug to be absorbed minimizing the diffusion barriers to 
increase the absorption period by prolonging the gastric 
residence time. Then, these beads were subsequently move 
to the upper part of the intestine, where they swelled more 
and release the drug. The results demonstrated that the 
ability of the beads to maintain dense blood glucose level. 
Thus FSM is a potential mucoadhesive agent in the 
development of controlled release formulations. 
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